{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:00:58Z","timestamp":1790614858078,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jid.2016.11.034","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T02:00:49Z","timestamp":1482285649000},"page":"1065-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis"],"prefix":"10.1016","volume":"137","author":[{"given":"Shih-Chi","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Dunant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Le Gouvello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Valeyrie-Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Sekula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia H.","family":"Kardaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Iu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.11.034_bib1","first-page":"462","article-title":"Upregulation of major histocompatibility complex class II, CD83, CD64, and CD14 on polymorphonuclear neutrophils stimulated with interleukin-15","volume":"41","author":"Abdel-Salam","year":"2008","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jid.2016.11.034_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","article-title":"Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome","volume":"151","author":"Abe","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2016.11.034_bib3","doi-asserted-by":"crossref","first-page":"47100","DOI":"10.1074\/jbc.M107385200","article-title":"Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression","volume":"276","author":"Ahn","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2016.11.034_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20020369","article-title":"Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells","volume":"195","author":"Becker","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2016.11.034_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","article-title":"Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex","volume":"52","author":"Bharadwaj","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jid.2016.11.034_bib9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Borchers","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2016.11.034_bib10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2133.2006.07211.x","article-title":"Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis spectrum","volume":"154","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"155","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/00365540310015935","article-title":"Cytokine cascade in sepsis","volume":"35","author":"Cavaillon","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jid.2016.11.034_bib13","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1136\/annrheumdis-2014-205577","article-title":"Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin","volume":"74","author":"Chung","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2016.11.034_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is\u00a0a key mediator for disseminated keratinocyte death in Stevens-Johnson\u00a0syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2016.11.034_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis","volume":"47","author":"Correia","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaad.2010.04.042","article-title":"Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"65","author":"Fujita","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1189\/jlb.0409222","article-title":"Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1","volume":"86","author":"Hogg","year":"2009","journal-title":"J\u00a0Leukocyte Biol"},{"key":"10.1016\/j.jid.2016.11.034_bib18","first-page":"1","article-title":"IL-6 signal transduction and its physiological roles: the signal orchestration model","volume":"149","author":"Kamimura","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.jid.2016.11.034_bib19","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.160.12.5742","article-title":"Targeting the IL-15 receptor with an antagonist IL-15 mutant\/Fc gamma2a protein blocks delayed-type hypersensitivity","volume":"160","author":"Kim","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.288.5466.675","article-title":"Control of homeostasis of CD8+ memory T cells by opposing cytokines","volume":"288","author":"Ku","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jid.2016.11.034_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm0297-189","article-title":"Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis","volume":"3","author":"McInnes","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2016.11.034_bib22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archdermatol.2011.239","article-title":"High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"147","author":"Nakajima","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-2133.2006.07436.x","article-title":"Increased mortality in toxic epidermal necrolysis with thalidomide: corroborating or exonerating the pathogenetic role of TNF-alpha?","volume":"155","author":"Namazi","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jid.2016.11.034_bib25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib26","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1346-8138.2010.01170.x","article-title":"Evaluation of serum cytokine levels in toxic epidermal necrolysis and Stevens-Johnson syndrome compared with other delayed-type adverse drug reactions","volume":"38","author":"Nomura","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000372-200010000-00005","article-title":"Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis","volume":"22","author":"Paquet","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jid.2016.11.034_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000083947","article-title":"Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome)","volume":"136","author":"Paquet","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2002.120563","article-title":"Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity","volume":"109","author":"Posadas","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib31","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2016.11.034_bib32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2016.11.034_bib33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jid.2016.11.034_bib34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2133.2012.10921.x","article-title":"Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome","volume":"167","author":"Saito","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jid.2016.11.034_bib36","doi-asserted-by":"crossref","first-page":"165974","DOI":"10.1155\/2013\/165974","article-title":"Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2014an updated view","volume":"2013","author":"Schulte","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jid.2016.11.034_bib37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.dsi.2013.09.002","article-title":"Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"31","author":"Su","year":"2013","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jid.2016.11.034_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/hepr.12421","article-title":"Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions","volume":"45","author":"Suda","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jid.2016.11.034_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2004.04.034","article-title":"Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions","volume":"114","author":"Tapia","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib41","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.4049\/jimmunol.175.5.3045","article-title":"Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides","volume":"175","author":"Tourkova","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","article-title":"The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens","volume":"17","author":"Waldmann","year":"1999","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2016.11.034_bib45","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2016.11.034_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1440-0960.1999.00342.x","article-title":"Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"40","author":"Wong","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jid.2016.11.034_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000148255","article-title":"Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis","volume":"217","author":"Yun","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2016.11.034_bib48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","article-title":"Potent and selective stimulation of memory-phenotype CD8+ T cells in\u00a0vivo by IL-15","volume":"8","author":"Zhang","year":"1998","journal-title":"Immunity"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1632797X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1632797X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T07:10:36Z","timestamp":1692601836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1632797X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0022202X1632797X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.11.034","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727142921.793575138","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}